These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 3091708

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.
    Campodónico VL, Llosa NJ, Bentancor LV, Maira-Litran T, Pier GB.
    Infect Immun; 2011 Aug; 79(8):3455-64. PubMed ID: 21628521
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.
    Cryz SJ, Mortimer P, Cross AS, Fürer E, Germanier R.
    Vaccine; 1986 Mar; 4(1):15-20. PubMed ID: 3962447
    [Abstract] [Full Text] [Related]

  • 46. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
    Bakht Azad S, Nikokar I, Faezi S, Rasooly S, Mahdavi M.
    Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Pseudomonas aeruginosa ribosomal vaccine. A comparison of the immunogenicity of vaccines from two different serotypes.
    Lieberman MM.
    Antibiot Chemother (1971); 1989 Oct; 42():193-202. PubMed ID: 2512837
    [No Abstract] [Full Text] [Related]

  • 49. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
    Kinoshita M, Kato H, Yasumoto H, Shimizu M, Hamaoka S, Naito Y, Akiyama K, Moriyama K, Sawa T.
    Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma.
    Campbell WN, Hendrix E, Cryz S, Cross AS.
    Clin Infect Dis; 1996 Jul; 23(1):179-81. PubMed ID: 8816151
    [Abstract] [Full Text] [Related]

  • 52. Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa.
    Hatano K, Boisot S, DesJardins D, Wright DC, Brisker J, Pier GB.
    Infect Immun; 1994 Sep; 62(9):3608-16. PubMed ID: 7520416
    [Abstract] [Full Text] [Related]

  • 53. Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.
    Konadu E, Shiloach J, Bryla DA, Robbins JB, Szu SC.
    Infect Immun; 1996 Jul; 64(7):2709-15. PubMed ID: 8698499
    [Abstract] [Full Text] [Related]

  • 54. Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.
    Gupta RK, Egan W, Bryla DA, Robbins JB, Szu SC.
    Infect Immun; 1995 Aug; 63(8):2805-10. PubMed ID: 7542631
    [Abstract] [Full Text] [Related]

  • 55. Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously.
    Edelman R, Taylor DN, Wasserman SS, McClain JB, Cross AS, Sadoff JC, Que JU, Cryz SJ.
    Vaccine; 1994 Nov; 12(14):1288-94. PubMed ID: 7856293
    [Abstract] [Full Text] [Related]

  • 56. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.
    Cryz SJ, Meadow PM, Fürer E, Germanier R.
    Eur J Clin Microbiol; 1985 Apr; 4(2):180-5. PubMed ID: 3924605
    [Abstract] [Full Text] [Related]

  • 57. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.
    Farjah A, Owlia P, Siadat SD, Mousavi SF, Ardestani MS, Mohammadpour HK.
    APMIS; 2015 Feb; 123(2):175-83. PubMed ID: 25470757
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Use of a vaccine for prevention of Pseudomonas aeruginosa infection of burn wounds in mice].
    Grochowski J, Bilinska M, Stankiewicz D, Arkusiewicz E.
    Pol Przegl Chir; 1979 Jun; 51(6):623-7. PubMed ID: 116210
    [No Abstract] [Full Text] [Related]

  • 60. Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains.
    Richmond P, Borrow R, Findlow J, Martin S, Thornton C, Cartwright K, Miller E.
    Infect Immun; 2001 Apr; 69(4):2378-82. PubMed ID: 11254596
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.